Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
BMJ 365, l1296
EpCAM-regulated carcinogenesis was proved to be associated with PI3K/Akt/mTOR signaling pathway activation in animal experimentation on prostatic cancer [84]
This landscape features major pharmaceutical companies developing GLP-1 therapies, service providers supporting clinical trials, regulatory agencies overseeing safety and efficacy, and end users such as hospitals, clinics, and home care settings
J Clin Pharmacol 2003;43(11):1257-1267
US$ 23.75
US$ 24.14
US$ 25.16
US$ 27.88
US$ 28.39
US$ 23.68
US$ 24.95
US$ 28.36
US$ 25.43
